A federal jury in Delaware has awarded $135.6 million in compensatory damages and $271.2 million in punitive damages against California-based Amgen Inc., according to this press release issued by the plaintiff.
The plaintiff, Regeneron Pharmaceuticals, Inc., accused Amgen of anticompetitive practices in pricing its drug Repatha, which competes with Regeneron’s Praluent.
The large punitive damages award in this case and in the Walmart case (see below) are a reminder that punitive damages are regularly awarded in corporation-versus-corporation lawsuits. Policy discussions about punitive damages often mistakenly assume that punitive damages are awarded only in cases involving “little guy” consumers suing big corporations.
